Adam Koppel - Director, Cerevel Therapeutics Holdings, Inc

As of June 14, 2021


Adam Koppel Net Worth

  • Net worth is estimated to be at least $3.14B
  • Owns at least 60,632,356 units of Cerevel Therapeutics Holdings, Inc stock

Adam Koppel Trading

  • Largest purchase of shares was 59,961,943 units , worth over $100M on October 29, 2020
  • In total has made about 3 transactions over a year
  • Usually trades in October, June and November, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Adam Koppel Mailing Address

  • Mailing address is C/o Brookside Capital, Llc John Hancock Tower, 200 Clarendon St Boston MA 02116 MA

Cerevel Therapeutics Holdings, Inc Insider Trading

  • The most recent transaction was 68,047 units bought on August 31, 2021 by Perceptive Advisors Llc, Perceptive Life Sciences Master Fund Ltd and Joseph Edelman worth over $2.06M
  • In the last year, insiders at Cerevel Therapeutics Holdings, Inc sold an estimated value of $38.74K and bought an estimated value of $352.57M
  • The most active traders are Paul Kuc, Chief Financial Officer,  Joseph Edelman, Director,  and Perceptive Advisors Llc, Director
  • Insider trading is most common in January, with the busiest year in 2021
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1